Abstract:Salmonella and Shigella species are food- and water-borne pathogens that are responsible for enteric infections in both humans and animals and are still the major cause of morbidity and mortality in the emerging countries. The existence of multiple Salmonella and Shigella serotypes as well as the emergence of strains resistant to antibiotics require the development of broadly protective therapies. Those bacteria utilize a Type III Secretion System (T3SS), necessary for their pathogenicity. The structural proteins composing the T3SS are common to all virulent Salmonella and Shigella spp., particularly the needle-tip proteins SipD (Salmonella) and IpaD (Shigella). We investigated the immunogenicity and protective efficacy of SipD and IpaD administered by intranasal and intragastric routes, in a mouse model of Salmonella enterica serotype Typhimurium (S. Typhimurium) intestinal challenge. Robust IgG (in all immunization routes) and IgA (in intranasal and oral immunization routes) antibody responses were induced against both proteins. Mice immunized with SipD or IpaD were protected against lethal intestinal challenge with S. Typhimurium or Shigella flexneri (100 Lethal Dose 50%). We have shown that SipD and IpaD are able to induce a cross-protection in a murine model of infection by Salmonella and Shigella. We provide the first demonstration that Salmonella and Shigella T3SS SipD and IpaD are promising antigens for the development of a cross-protective Salmonella-Shigella vaccine. These results open the way to the development of cross-protective therapeutic molecules.Salmonella and Shigella are responsible for gastrointestinal diseases and continue to remain a serious health hazard in South and South-East Asia and African countries, even more with the emergence of multi drug resistances. Developed vaccines are either not commercialized (for Shigella) or cover only a limited number of serotypes (for Salmonella). There is thus a crucial need to develop cross-protective therapies. By targeting proteins SipD and IpaD belonging respectively to the injectisome of Salmonella and Shigella and necessary to their virulence, we have shown that these proteins are able to induce immune response and a cross-protection in a murine model of infection by Salmonella and Shigella despite relatively weak identity sequence (38%). Such a candidate vaccine offers promising perspectives to control Salmonella and Shigella diseases.

Roles of the Crp and Sipb Genes of Salmonella Enterica Serovar Typhimurium in Protective Efficacy and Immune Responses to Vaccination in Mice.

Biological Characteristics of the △crp△sipb Mutant Strain of Salmonella Typhimurium SL1344

Immunological Responses Against Salmonella Enterica Serovar Typhimurium Braun Lipoprotein and Lipid A Mutant Strains in Swiss-Webster Mice: Potential Use As Live-Attenuated Vaccines.

Recombinant SpaO and H1a as immunogens for protection of mice from lethal infection with Salmonella paratyphi A: implications for rational design of typhoid fever vaccines.

Generation and evaluation of Salmonella enterica serovar Choleraesuis mutant strains as a potential live-attenuated vaccine

Differential Immune Responses of C57BL/6 Mice to Infection by Salmonella Enterica Serovar Typhimurium Strain SL1344, CVCC541 and CMCC50115

Reversible Synthesis of Colanic Acid and O-antigen Polysaccharides in Salmonella Typhimurium Enhances Induction of Cross-Immune Responses and Provides Protection Against Heterologous Salmonella Challenge.

Immunogenicity and Protection Efficacy of a Salmonella Enterica Serovar Typhimurium Fnr, Arca and Flic Mutant.

Construction and characterization of invasion protein B gene deleted mutant of Salmonella typhimurium SL1344 strain

Identification of an outer membrane protein of Salmonella enterica serovar Typhimurium as a potential vaccine candidate for Salmonellosis in mice.

Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium.

Oral immunization of mice and swine with an attenuated Salmonella choleraesuis [delta cya-12 delta(crp-cdt)19] mutant containing a recombinant plasmid

Invasion of Salmonella typhimuriumSL1344 △crp and△sipB mutants

Deletion of Invasion Protein B in Salmonella Enterica Serovar Typhimurium Influences Bacterial Invasion and Virulence

Immunogenicity And Cross-Protective Efficacy Induced By Outer Membrane Proteins From Salmonella Typhimurium Mutants With Truncated Lps In Mice

Physiology, Pathogenicity and Immunogenicity of Live, Attenuated Salmonella Enterica Serovar Enteritidis Mutants in Chicks

SipD and IpaD induce a cross-protection against Shigella and Salmonella infections

Outer Membrane Vesicles Derived from Salmonella Typhimurium Mutants with Truncated LPS Induce Cross-Protective Immune Responses Against Infection of Salmonella Enterica Serovars in the Mouse Model.

Protective effects of a supernatant factor from Salmonella typhimurium on Salmonella typhimurium infection of inbred mice

Salmonella spvC Gene Inhibits Pyroptosis and Intestinal Inflammation to Aggravate Systemic Infection in Mice

Oral immunization of mice with attenuated Salmonella typhimurium containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortus